Clinical trial
Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical…
NCT00156611 · University Hospital Tuebingen, Other · Unknown status
Key facts
| NCT number | NCT00156611 |
|---|---|
| Title | Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease |
| Official title | ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease - A Randomized Prospective Trial (RIO-Trial) |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | University of Bern |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug, Procedure |
| Interventions | Balloon Angioplasty, ReoPro |
| Enrollment | 420 |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: